NEW YORK — Women's health diagnostic firm Progenity on Thursday announced a 70 percent drop in second quarter revenues, its first financial results since going public earlier this year.
For the three-month period ended June 30, Progenity reported $17.3 million in revenue, down from $57.2 million in the year-ago quarter. Second quarter revenues were impacted by "a $10.3 million accrual for refunds to government payors," the firm said in a statement.